It is now over ten years since the first International Symposium on the Clinical Aspects of Paraquat Poisoning was held in Manchester, England. 1 More recently a WHO monograph2 on paraquat and diquat has reviewed the action, uses, kinetics and clinical effects of these herbicides following both occupational exposure, and accidental and suicidal poisoning. Treatment was not, however, considered in any detail in the WHO Report. Because of this, we felt it appropriate to organise a second symposium, the purpose of which was to obtain a European consensus on the most effective forms of treatment.
ing publication represents a comprehensive summary of the epidemiology, clinical features and management of paraquat poisoning.
Clinicians might ask why paraquat is used at all, given its potential toxicity. The uses and usefulness of paraquat were reviewed by Professor G. Sagar.3 3 Paraquat has many advantageous properties; it is a relatively non-selective, rain-fast, foliage-applied contact herbicide which is inactivated on contact with most types of soil. Thus, no biologically active residues remain in the soil and planting and sowing may be carried out almost immediately after spraying. It has been estimated that in Europe alone 5 x 106 hectares are sprayed with this herbicide annually and that it is now used in over 130 countries. As yet there is no alternative herbicide which possesses all of paraquat's agrochemical characteristics.
Dr B. Hart reported that paraquat has an excellent safety record if used as directed, and that this has been confirmed by several field studies.4 Understandably some of the recommended precautions such as the wearing of protective clothing, or a face mask, are not always complied with., especially in tropical conditions. In most cases this does not affect the safety of the product, though the prolonged wearing of clothing contaminated with inadequately diluted paraquat concentrate may result in extensive and severe skin damage, systemic toxicity and, rarely, death. More commonly, minor and reversible injuries to the skin, eyes, nose and nails occur, usually due to poor hygiene or poor agricultural practice. Dr G. Volans presented data on paraquat poisoning in the U.K. over the twenty-year period since the first fatalities were recorded and examined in detail data for the last six years.s In the U.K., fatalities due to accidental poisoning have remained below ten per year and no children have died from paraquat poisoning since 1977. Currently fewer than 50 adults die each year from the deliberate ingestion of paraquat.
In contrast there were estimated to be more than 1300 fatalities from this cause in Japan in 1984. 6 6 Difficulties were found in attempting to compare morbidity and mortality data for paraquat between different countries. The meeting debated this point and consequent to this discussion a paper has been presented to a meeting of the European Association of Poison Control Centres and the World Federation of Clinical Toxicology Centres' in order to establish a scheme for standardisation of data collection, using paraquat as a model. A number of countries have since agreed to a pilot scheme with the support of the International Programme on Chemical Safety.
Against this background, the likely effects of preventive measures already introduced were reviewed. Labelling, even if in an appropriate language is unlikely to deter the determined suicide. Moreover, extensive media coverage about the potential toxicity of paraquat may increase the likelihood of suicide.
Changes in the formulation of paraquat-for instance the addition of colour, stench and, more particularly, an emetic-have been introduced but have not yet been evaluated satisfactorily. Although several authors have expressed an opinion on the value of the emetic, none have produced adequate evidence to support their conclusions, yet it is disappointing that the addition of an emetic does not appear to have affected mortality significantly. Two further suggestions were made at the Symposium which might help to prevent serious intoxication, even in attempted suicide, and both provoked considerable interest. The first of these was that there should be a reduction in the concentration of the marketed concentrate from 20% w/v to either 10% W/VS,8 or 5% w/v.9 The second suggestion was that paraquat could be reformulated to contain a natural thickening agent as demonstrated by Professor Naito.6 When this formulation is mixed with small amounts of water a semi-solid mixture is produced which would make it difficult to ingest large quantities. Unfortunately this formulation is, as yet, only at an early stage of development and further work on its herbicidal performance is necessary. The results of these studies are awaited with interest.
Lastly, in terms of prevention, reduction of availability might be effective in limiting suicidal fatalities.
Paraquat has been banned in some countries, for example, West Germany, Sweden and Norway, though not necessarily for toxicological reasons. Such a measure would in time result in the disappearance of paraquat poisoning though it is probable that the determined suicide would substitute equally toxic alternatives. As a result a valuable herbicide would be lost without any diminution in poisoning fatalities. All proposed preventive measures must be considered in toxicological terms initially and then balanced against the agricultural needs of the country concerned.
The clinical features of systemic toxicity were summarised by Dr A Value. 10 Systemic toxicity more commonly occurs following the ingestion or injection of paraquat. Three degrees of intoxication may be distinguished; mild poisoning (< 20 mg paraquat ion/kg body weight); moderate to severe poisoning (20-40 mg paraquat ion/kg body weight) and acute fulminant poisoning (> 40 mg paraquat ion/kg body weight). Whereas in mild poisoning all patients recover fully and suffer only minimal gastrointestinal symptoms, the majority of patients in the other categories die. In the case of moderate to severe poisoning death is normally delayed two or three weeks and renal failure and pulmonary fibrosis occur. On the other hand, in acute fulminant poisoning multiple organ failure occurs early and death is never delayed for more than a few days.
The most characteristic feature of paraquat poisoning is lung damage. This may be explained by the biochemical mechanisms of toxicity summarised by Dr L. Smith. 11 Paraquat is selectively accumulated in the lung by an energy dependent diamine transport process located in the alveolar epithelial cells and Clara cells of the airways. Paraquat is thought to exert its cellular toxicity by undergoing cyclic oxidation and reduction (redox cycling) to produce free radicals, such as superoxide, and to deplete NADPH. The biochemical consequences of these changes are not clear but may include direct cellular damage by free radicals, e.g. lipid peroxidation, and disruption of essential physiological and biochemical functions, by changes in cellular NADPH and other co-factors and enzymes. Direct evidence of lipid peroxidation in vivo is scarce but it is encouraging to see that preliminary studies in man do provide support for this hypothesis.l2 Although the biochemical mechan-isms of paraquat toxicity are being resolved, inhibition of redox cycling in vivo has not been achieved. Until the biochemical events leading to cell death have been identified more specific treatments cannot be developed.
Professor D. Davies reviewed the pharmacokinetics of paraquat.l3 Data on paraquat absorption in man is sparse but suggests that absorption from the gastrointestinal tract is rapid but incomplete, as in the dog, with peak plasma concentrations occurring at approximately 2 h after ingestion. Thus, procedures to clear paraquat from the gut more than 4-6 h after ingestion are unlikely to be useful and may remove little more than that proportion of the dose which will not be absorbed. It has been proposed that the distribution of paraquat in the body is best described by a three-compartment open model with input to, and elimination from, the central compartment, (the blood). In a computer simulation, the early onset of renal failure produced a five-fold increase in plasma levels of paraquat. Preliminary work in dogs suggests that concentrations of paraquat in the lung may be greatly influenced by the time of onset and degree of renal failure. Thus the biochemical and pharmacokinetic aspects of paraquat poisoning have been identified in some detail. Subsequent speakers repeatedly referred back to this knowledge in discussing treatment but it was clear that in the past many treatments had been proposed without making such reference.
The management of paraquat poisoning was reviewed critically by several contributors. There was agreement that measures to relieve distress and the symptoms caused by ulceration of the oropharynx were of far greater importance than the inappropriate use of heroic measures in patients who, on the basis of quantitative plasma or urine analysis 14, IS were unlikely to survived. 10
Methods to prevent absorption of paraquat were reviewed by Dr. T. Meredith. 16 Although animal work suggests that activated charcoal 17 and kayexalate'8 reduce the mortality if given within three to four hours of dosing with paraquat, there is no conclusive evidence in man that the use of any method to prevent absorption alters the clinical course of paraquat poisoning. ot2 Dr C. Bismuth&dquo; and Dr A. Proudfoot2o assessed the value of haemodialysis and haemoperfusion in increasing the elimination of paraquat following absorption. It was considered unlikely that modification of toxicokinetics by such techniques would improve the treatment of paraquat poisoning as they are usually carried out after a lethal amount of paraquat has been taken up by vital organs. Prolonged haemoperfusion in the small number of patients who are moderately poisoned with paraquat, and who develop early renal failure may be of value, if carried out within 6-18 h of absorption. 13 It was also considered pertinent to look again at the use of peritoneal dialysis using new osmotic agents. Although this technique is inferior to both haemodialysis and haemoperfusion at removing paraquat, it has the advantage of speed of institution and ease of use. '3 Appraisal of many of the treatment regimens is limited by the lack of adequate supporting analytical data. This was considered by several contributors. Wider use of the qualitative 'spot test' for paraquat, with positive and negative controls, or the development of a more rapid and sensitive assay, perhaps using fluro-and enzyme-immunoassay should be investigated.l4 Work was presented aimed both at validating qualitative results of the 'spot test' for paraquat and extending the paraquat prognosis curve of Proudfoot et ai.21 beyond 24 h. 15 Dr N. Bateman reviewed the efficacy of a wide range of pharmacological treatments in paraquat poisoning. As yet there is no convincing evidence of benefit from the use of superoxide dismutase, propranolol, Vitamin E, ascorbic acid, riboflavin, niacin, desferrioxamine, selenium, clofibrate, acetylcysteine or corticosteroids. Attention was again drawn to the lack of both clinical trials data and information concerning plasma paraquat levels in many of the published papers. The ideal pharmacological antagonist for paraquat seems as far away as ever. Dr M Williams reported the clinical course of five patients poisoned with paraquat who had received lung irradiation, and reviewed the literature concerning patients recovering from paraquat lung without active therapy.23 Although the outcome of the five patients irradiated was not encouraging (four out of five died), attention was drawn to the number of patients that would be necessary to evaluate scientifically such a treatment, and the poor quality of published material in the scientific press. 24 A report of an immunosuppressant regimen24 to reduce the acute alveolitis caused by paraquat. may be read with similar limitations in mind.2 ,26 Only 25 of Addo and Poon-King's 72 patients had plasma concentrations of paraquat measured. Although it is true to say that in six of these cases insignificant amounts of paraquat were detected, of the remaining 19 patients, seven lived despite the chances of survival, assessed from the survival curves of Hart et ai. 27, being 30% or less. It is possible that in less severely poisoned patients, the use of immunosuppressives might be of value, though most physicians would feel that more detailed research is required before cyclophosphamide treatment can be recommended. Animal data presented at the Symposium28 is not encouraging however, since no benefit was noted unless cyclophosphamide and dexamethasone were administered for 48 h prior to dosing. The epidemiology and clinical features of paraquat poisoning are now well documented. There was wide agreement at the Symposium that there is at present no effective treatment for those severely poisoned individuals who have ingested substantial amounts of a concentrated formulation of paraquat. Equally, those who ingest less than a sachet of one of the granular preparations will survive even without treatment. In the middle are the small number of patients, at least in Europe, who might benefit from the use of prolonged haemoperfusion or other treatments. However, the number of patients required to evaluate prospectively such treatment are not available at any single European centre and therefore multicentre-studies are necessary. Until these trials are complete the recommendation that the concentration of the liquid preparations should be reduced is worthy of full consideration by the manufacturers and distributors.
It is probable that clinicians will continue to employ methods to decrease the absorption and increase the elimination of paraquat, even though there is no definite evidence of benefit, simply because a potentially fatal condition stimulates the innate desire of many doctors to 'do something'. At present in the majority of severely poisoned patients, attention could be more profitably directed to providing better terminal care. 1 In summary, although ten years have elapsed since the first Symposium, the treatment of paraquat poisoning is no more satisfactory now than it was then. A decade ago haemoperfusion was thought to hold out the best promise but this has not proved to be the case. Aside from the preventive measures mentioned above, a greater understanding of the biochemical mechanisms of paraquat toxicity, together with pharmacological research to produce an agent capable of reversing biochemical damage, or blocking uptake into the lungs, seem the most hopeful approaches to this difficult clinical problem.
We hope that these proceedings stimulate further discussion and research.
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